Translational Development Acquisition TDACU
NASDAQ TDACU
$11.48 +0.00 (+0.00%)
At close: Nov 5, 2026 · 4:00 PM EST

Translational Development Acquisition (TDACU) Current Assets (2023 - 2026)

Updated

Translational Development Acquisition (TDACU) reported Current Assets of $104,731 for Q2 2026, down 32.9% from $156,077 a year earlier but up 39.1% from the prior quarter.

Analysis

Translational Development Acquisition (TDACU) Current Assets (2023 - 2026) Analysis & Trends

At the end of FY2025, Translational Development Acquisition posted Current Assets of $39,465, down 93.9% from FY2024.

  • By year, Current Assets came in at $650,233 in FY2024 and $2,021 in FY2023.
  • Five-year quarterly Current Assets spans a low of $2,021 in Q4 2023 and a high of $650,233 in Q4 2024.
  • Year over year, Current Assets has now declined in each of the last three quarters.
  • Per Business Quant data, the three quarters before Q2 2026 came in at $75,316 (Q1 2026), $39,465 (Q4 2025) and $80,582 (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 104,731.00
Mar 31, 2026 75,316.00
Dec 31, 2025 39,465.00
Sep 30, 2025 80,582.00
Jun 30, 2025 156,077.00
Mar 31, 2025 415,422.00
Dec 31, 2024 650,233.00
Dec 31, 2023 2,021.00
API Access

Translational Development Acquisition Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-assets&ticker=TDACU&period=max&api_key=YOUR_API_KEY